logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Paul Shartzer Dietrich

This inventor holds 11 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Syntex (u.s.a.) Inc., Novartis Ag, Roche Palo Alto LLC. Active years: 1994-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Shartzer Dietrich. Retrieved from https://idiyas.com/inventor/paul-shartzer-dietrich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 81.8


Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 135(Granted Patents)


Company Filing History:

goldMedal4 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
silverMedal2 out of 3,977 
 
Novartis Ag
 patents
bronzeMedal2 out of 322 
 
Roche Palo Alto LLC
 patents
4. 1 out of 1,426 
 
Iowa State University Research Foundation Inc.
 patents
5. 1 out of 1,603 
 
Sandoz Gmbh
 patents
6. 1 out of 834,513 
Other
 patents

Years Active: 1994-2013

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 8349572 - Stable cell lines expressing hERG (2013-01-08),
2. 7776590 - Stable cell lines expressing hERG (2010-08-17),
3. 6893842 - T-type calcium channel variants; compositions thereof; and uses (2005-05-17),
4. 6589787 - T-type calcium channel variants; compositions thereof; and uses (2003-07-08),
5. 6335172 - Cloned tetrodotoxin-sensitive sodium channel &agr;-subunit and a splice variant thereof (2002-01-01),
6. 6309858 - T-type calcium channel variants; compositions thereof; and uses (2001-10-30),
7. 6114608 - Nucleic acid construct comprising bacillus thuringiensis cry1Ab gene (2000-09-05),
8. 6040185 - Genetic stabilizing elements (2000-03-21),
9. 6030810 - Cloned tetrodotoxin-sensitive sodium channel .alpha.-subunit and a (2000-02-29),
10. 5633363 - Root preferential promoter (1997-05-27),
11. 5371003 - Electrotransformation process (1994-12-06),

Title: Paul Shartzer Dietrich: Innovator in Cell Line Technology

Introduction

Paul Shartzer Dietrich is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of biotechnology, particularly in the development of stable cell lines. With a total of 11 patents, his work has had a lasting impact on research and development in this area.

Latest Patents

Among his latest patents, Dietrich has developed a stable eukaryotic cell line that expresses hERG, which exhibits a stable current under electrophysiological test conditions. This innovation is crucial for various applications in pharmacology and toxicology, providing researchers with reliable tools for studying ion channels.

Career Highlights

Throughout his career, Dietrich has worked with prominent companies such as Syntex Inc. and Novartis AG. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in biotechnology.

Collaborations

Dietrich has collaborated with several esteemed professionals in his field, including Ralph M. Sinibaldi and Stephen Gregory Delgado. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Paul Shartzer Dietrich's contributions to biotechnology, particularly in the development of stable cell lines, highlight his role as a leading inventor in the industry. His work continues to influence research and development in significant ways.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…